No abstract

Background: Contraception helps prevent unintended pregnancies and mother to child Human Immune Virus (HIV) transmission among human immune virus positive women. Ethiopia has made remarkable progress in increasing contraceptive use rate but there is still a disparity of contraceptive use in the country. Understanding the extent of and barriers of contraceptive use among HIV positive women in Ethiopia is important for learning how to best improve level of contraceptive use among this group of population. Therefore, this study aimed to determine contraceptives use and associated factors among HIV positive sexually active women at anti-retroviral therapy clinic at Felege Hiwot Referral Hospital ART clinic in Bahir Dar, Ethiopia.Method: A facility-based cross-sectional study was conducted from June 01-30, 2018 among (n=308) randomly selected HIV positive women at Felege Hiwot Referral Hospital. Data were collected using a pretested interviewer-administered questionnaire and analyzed using SPSS version20. Logistic regression analysis was employed to identify determinants of contraceptive use. Statistical significance was declared at p-value <0.05.Results: Out of three hundred eight participants, 118(38.3%) reported contraceptive use at the time of the study. Injectable is the most preferred (43.5%) contraceptive method. Participants with age 15-34 years (AOR =3.09, 95%CI: 1.59-5.99), disclosed their status to sex partner, (AOR=2.7, 95%CI: 1.14-6.66), had history of contraception use; (AOR=3.36, 95%CI: 1.68-6.74), were sexually active in the last six months (AOR=5.45, 95%CI: 2.72-10.91) had higher odds of contraceptive use. However, participants who had drinking habit (AOR=4.35, 95%CI: 1.82-10.38) had lower odds of contraceptive use.Conclusion: A significant proportion of HIV positive women had low level of contraceptive use that was lower than the national recommended level. These results suggest that multi-sectorial and multi-disciplinary approaches are needed to increase contraceptive use in the HIV positive women. Emphasis should be given for HIV positive women who have drinking habit and older age women.

Back ground: Contraception helps prevent unplanned pregnancies and mother to child HIV transmission among human immune virus positive women. Contraceptive use status and associated factors were not well addressed in the study area. This study aimed to assess contraceptives use and associated factors among HIV positive sexually active women at anti-retroviral therapy clinic in Felege Hiwot Referral Hospital, Northwest Ethiopia. Method : A facility based quantitative cross-sectional study was conducted from June 01 -30, 2018, among 308 randomly selected sexually active HIV positive women of reproductive age in Felege Hiwot Referral Hospital anti-retro viral treatment clinic. A pre-tested interviewer-administered questionnaire was used to collect data. Data were analyzed using SPSS version20. Descriptive statistics were used to summarize socio-demographic characteristics of participants. A multivariate logistic regression analysis method was employed and odds ratio with 95% confidence interval was used to control possible confounders. Statistical significance was declared at p-value <0.05. Results: The current study revealed that overall contraception use among sexually active HIV positive women was 38.3 %( 95%CI: 32.5%-43.5%). Women with age range of 15-34 years old (AOR =3.089, 95%CI: 1.591-5.999), HIV status disclosure to sex partner, (AOR=2.75995%CI: 1.142-6.663), previous contraception utilization experience; (AOR=3.361, 95%CI: 1.677-6.736), Sexual activity in the last six months (AOR5.451, 95%CI: 2.724-10.908) and had drinking habit (AOR=4.351, 95%CI: 1.824-10.379) were the main predictors of contraceptive use. Conclusion: Contraceptive use was low in the current study area. Efforts should be strengthened to increase contraception use among human immune virus positive women. Anti-retro viral treatment and family planning services should be integrated to increase contraceptive use uptake in the study area. Keywords: Contraceptive use, Contraception, Human immune virus positive women, Bahir Dar, North west Ethiopia.